Okuma T, Koga I, Uchida Y
Psychopharmacology (Berl). 1976 Dec 21;51(1):101-5. doi: 10.1007/BF00426329.
For the purpose of quantitative demonstration of the sensitivity to chlorpromazine (CPZ) effects on brain functions of schizophrenics and normal subjects, polygraphic recordings of electroencephalogram (EEG) and electrodermal response (EDR) were performed before and 3 h after oral administration of 25 mg of CPZ: percent time waking EEG (per cent W-EEG) and number per minute of EDR were measured during the resting period and the period of calculation. In 10 normal adult subject, both per cent W-EEG and number of EDR showed remarkable decrease after CPZ administration. In 22 schizophrenics, however, per cent W-EEG showed no significant decrease after CPZ administration. Number of EDR in schizophrenics during the period of calculation did not show any significant decrease. The neural mechanism underlying the lower sensitivity to CPZ effects in schizophrenics was discussed.
为定量证明氯丙嗪(CPZ)对精神分裂症患者和正常受试者脑功能影响的敏感性,在口服25 mg CPZ之前和之后3小时进行脑电图(EEG)和皮肤电反应(EDR)的多导记录:在静息期和计算期测量清醒脑电图时间百分比(W-EEG百分比)和每分钟EDR次数。在10名正常成年受试者中,服用CPZ后W-EEG百分比和EDR次数均显著下降。然而,在22名精神分裂症患者中,服用CPZ后W-EEG百分比没有显著下降。精神分裂症患者在计算期的EDR次数没有显著下降。讨论了精神分裂症患者对CPZ作用敏感性较低的神经机制。